| RS113902534 |
FBN1
|
Health Risk |
Pathogenic |
Familial thoracic aortic aneurysm and aortic dissection, Marfan syndrome |
| RS113904256 |
FBN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Stiff skin syndrome, Marfan syndrome |
| RS113905529 |
FBN1
|
Health Risk |
Pathogenic/Likely pathogenic |
Marfan syndrome, Familial thoracic aortic aneurysm and aortic dissection |
| RS113908000 |
SNF8
|
Health Risk |
Pathogenic |
SNF8-associated disease, Neurodevelopmental disorder plus optic atrophy |
| RS113913634 |
PREPL
|
Health Risk |
Conflicting classifications of pathogenicity |
Myasthenic syndrome, congenital |
| RS113916636 |
NEB
|
Health Risk |
Likely pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS113917021 |
FZD4
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS113917053 |
STAB2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS113920122 |
SALL4
|
Health Risk |
Conflicting classifications of pathogenicity |
Duane-radial ray syndrome, Inborn genetic diseases |
| RS113925756 |
CELSR2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS113925788 |
NEB
|
Health Risk |
Likely pathogenic |
Nemaline myopathy 2, Arthrogryposis multiplex congenita 6 |
| RS113928116 |
RYR1
|
Health Risk |
Conflicting classifications of pathogenicity |
RYR1-related disorder, Malignant hyperthermia |
| RS113929946 |
CACNA1C
|
Health Risk |
Conflicting classifications of pathogenicity |
Long QT syndrome, Cardiovascular phenotype |
| RS113930974 |
ENG
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary hemorrhagic telangiectasia, Cardiovascular phenotype |
| RS113930991 |
MYH11
|
Health Risk |
Likely pathogenic |
Aortic aneurysm, familial thoracic 4 |
| RS113931414 |
RET
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Multiple endocrine neoplasia |
| RS113932941 |
CYBA
|
Health Risk |
Pathogenic |
Granulomatous disease, chronic |
| RS113935744 |
FBN1
|
Health Risk |
Pathogenic/Likely pathogenic |
Marfan syndrome, Familial thoracic aortic aneurysm and aortic dissection |
| RS113936232 |
CTSD
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuronal ceroid lipofuscinosis 10, Neuronal ceroid lipofuscinosis |
| RS113938044 |
ADGRV1
|
Health Risk |
Conflicting classifications of pathogenicity |
Usher syndrome type 2C, Usher syndrome type 2C |
| RS113938200 |
MASP1
|
Health Risk |
Conflicting classifications of pathogenicity |
3MC syndrome 1, Monogenic hearing loss |
| RS113938624 |
CHD7
|
Health Risk |
Conflicting classifications of pathogenicity |
CHARGE syndrome, Hypogonadotropic hypogonadism 5 with or without anosmia |
| RS113944762 |
DOCK8
|
Health Risk |
Pathogenic |
Combined immunodeficiency due to DOCK8 deficiency, Combined immunodeficiency due to DOCK8 deficiency |
| RS113947687 |
SERPINF1
|
Health Risk |
Likely pathogenic |
— |
| RS113950465 |
COL1A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Osteogenesis imperfecta, Osteogenesis imperfecta type I |
| RS113951193 |
PLP1
|
Health Risk |
Likely pathogenic |
Pelizaeus-Merzbacher disease, Pelizaeus-Merzbacher disease |
| RS1139522 |
ABAT
|
Health Risk |
Conflicting classifications of pathogenicity |
Gamma-aminobutyric acid transaminase deficiency, Gamma-aminobutyric acid transaminase deficiency |
| RS113954699 |
ST3GAL3
|
Health Risk |
Conflicting classifications of pathogenicity |
Nonpapillary renal cell carcinoma, Nonpapillary renal cell carcinoma |
| RS113954997 |
RRAS2
|
Health Risk |
Pathogenic |
Noonan syndrome 12, Ovarian neoplasm |
| RS113962887 |
GGCX
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS113962905 |
SYNE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive ataxia, Beauce type |
| RS113963967 |
FBN1
|
Health Risk |
Pathogenic/Likely pathogenic |
Marfan syndrome, Familial thoracic aortic aneurysm and aortic dissection |
| RS113967308 |
DSP
|
Health Risk |
Conflicting classifications of pathogenicity |
Arrhythmogenic cardiomyopathy with wooly hair and keratoderma, Arrhythmogenic right ventricular dysplasia 8 |
| RS113967847 |
ELP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial dysautonomia, Familial dysautonomia |
| RS113972139 |
LDLR
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypercholesterolemia, familial |
| RS113972676 |
FLNC
|
Health Risk |
Pathogenic/Likely pathogenic |
Cardiovascular phenotype, Hypertrophic cardiomyopathy 26 |
| RS113981920 |
TSEN2
|
Health Risk |
Conflicting classifications of pathogenicity |
Pontoneocerebellar hypoplasia, Pontoneocerebellar hypoplasia |
| RS113982129 |
TCIRG1
|
Health Risk |
Likely pathogenic |
— |
| RS113984451 |
COL1A1
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type I, Osteogenesis imperfecta type I |
| RS113984578 |
TNNT2
|
Health Risk |
Likely pathogenic |
— |
| RS113989128 |
LRRK1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, LRRK1-related disorder |
| RS113989591 |
MYH11
|
Health Risk |
Likely pathogenic |
Aortic aneurysm, familial thoracic 4 |
| RS113993943 |
GLA
|
Health Risk |
Likely pathogenic |
Fabry disease, Fabry disease |
| RS113993945 |
IDS
|
Health Risk |
Pathogenic/Likely pathogenic |
Mucopolysaccharidosis, MPS-II |
| RS113993946 |
IDS
|
Health Risk |
Pathogenic/Likely pathogenic |
Mucopolysaccharidosis type 2, severe form |
| RS113993947 |
IDS
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis, MPS-II |
| RS113993948 |
IDS
|
Health Risk |
Pathogenic/Likely pathogenic |
Mucopolysaccharidosis, MPS-II |
| RS113993949 |
IDS
|
Health Risk |
Pathogenic/Likely pathogenic |
Mucopolysaccharidosis, MPS-II |
| RS113993951 |
IDS
|
Health Risk |
Likely pathogenic |
Mucopolysaccharidosis, MPS-II |
| RS113993952 |
IDS
|
Health Risk |
Conflicting classifications of pathogenicity |
Mucopolysaccharidosis, MPS-II |
| RS113993953 |
IDS
|
Health Risk |
Conflicting classifications of pathogenicity |
Mucopolysaccharidosis, MPS-II |
| RS113993954 |
IDS
|
Health Risk |
Pathogenic/Likely pathogenic |
Mucopolysaccharidosis, MPS-II |
| RS113993955 |
IDS
|
Health Risk |
Pathogenic/Likely pathogenic |
Mucopolysaccharidosis, MPS-II |
| RS113993956 |
MYH14
|
Health Risk |
Pathogenic |
Peripheral neuropathy-myopathy-hoarseness-hearing loss syndrome, Peripheral neuropathy-myopathy-hoarseness-hearing loss syndrome |
| RS113993958 |
CFTR
|
Health Risk |
Likely pathogenic |
Cystic fibrosis, ivacaftor response - Efficacy |
| RS113993959 |
CFTR
|
Health Risk |
Pathogenic |
Cystic fibrosis, Hereditary pancreatitis |
| RS113993960 |
CFTR
|
Health Risk |
Pathogenic |
Cystic fibrosis, Bronchiectasis with or without elevated sweat chloride 1 |
| RS113993961 |
WRN
|
Health Risk |
Pathogenic |
Werner syndrome, Werner syndrome |
| RS113993962 |
BLM
|
Health Risk |
Pathogenic/Likely pathogenic |
Bloom syndrome, Hereditary cancer-predisposing syndrome |
| RS113993963 |
TP63
|
Health Risk |
Pathogenic |
ADULT syndrome, ADULT syndrome |
| RS113993965 |
TP63
|
Health Risk |
Pathogenic |
TP63-Related Spectrum Disorders, TP63-Related Spectrum Disorders |
| RS113993966 |
TP63
|
Health Risk |
Pathogenic/Likely pathogenic |
ADULT syndrome, TP63-related disorder |
| RS113993967 |
TP63
|
Health Risk |
Pathogenic/Likely pathogenic |
ADULT syndrome, TP63-Related Spectrum Disorders |
| RS113993968 |
HTRA1
|
Health Risk |
Pathogenic |
CARASIL syndrome, Cerebral arteriopathy |
| RS113993969 |
HTRA1
|
Health Risk |
Pathogenic |
CARASIL syndrome, CARASIL syndrome |
| RS113993970 |
HTRA1
|
Health Risk |
Pathogenic/Likely pathogenic |
CARASIL syndrome, Cognitive impairment |
| RS113993971 |
HTRA1
|
Health Risk |
Pathogenic/Likely pathogenic |
CARASIL syndrome, HTRA1-related cerebral small vessel disease |
| RS113993973 |
PYGL
|
Health Risk |
Pathogenic |
Glycogen storage disease, type VI |
| RS113993974 |
PYGL
|
Health Risk |
Pathogenic |
Glycogen storage disease, type VI |
| RS113993975 |
PYGL
|
Health Risk |
Pathogenic |
Glycogen storage disease, type VI |
| RS113993976 |
PYGL
|
Health Risk |
Pathogenic |
Glycogen storage disease, type VI |
| RS113993977 |
PYGL
|
Health Risk |
Pathogenic |
Glycogen storage disease, type VI |
| RS113993978 |
PYGL
|
Health Risk |
Pathogenic |
Glycogen storage disease, type VI |
| RS113993979 |
PYGL
|
Health Risk |
Pathogenic/Likely pathogenic |
Glycogen storage disease, type VI |
| RS113993980 |
PYGL
|
Health Risk |
Conflicting classifications of pathogenicity |
Glycogen storage disease, type VI |
| RS113993981 |
PYGL
|
Health Risk |
Pathogenic |
Glycogen storage disease, type VI |
| RS113993982 |
PYGL
|
Health Risk |
Pathogenic |
Glycogen storage disease, type VI |
| RS113993986 |
PYGL
|
Health Risk |
Likely pathogenic |
Glycogen storage disease, type VI |
| RS113993990 |
SBDS
|
Health Risk |
Pathogenic |
Shwachman-Diamond syndrome 1, Aplastic anemia |
| RS113993991 |
SBDS
|
Health Risk |
Pathogenic |
Shwachman-Diamond syndrome 1, Inborn genetic diseases |
| RS113993992 |
SBDS
|
Health Risk |
Pathogenic |
Shwachman-Diamond syndrome 1, Aplastic anemia |
| RS113993993 |
SBDS
|
Health Risk |
Pathogenic/Likely pathogenic |
Aplastic anemia, susceptibility to |
| RS113993994 |
SBDS
|
Health Risk |
Pathogenic |
Shwachman-Diamond syndrome 1, Aplastic anemia |
| RS113993996 |
SBDS
|
Health Risk |
Conflicting classifications of pathogenicity |
Shwachman-Diamond syndrome 1, Aplastic anemia |
| RS113993997 |
SBDS
|
Health Risk |
Likely pathogenic |
Shwachman-Diamond syndrome 1, Aplastic anemia |
| RS113993998 |
SBDS
|
Health Risk |
Pathogenic/Likely pathogenic |
Shwachman-Diamond syndrome 1, Aplastic anemia |
| RS113994006 |
EIF2B1
|
Health Risk |
Conflicting classifications of pathogenicity |
Vanishing white matter disease, Leukoencephalopathy with vanishing white matter 1 |
| RS113994011 |
EIF2B2
|
Health Risk |
Likely pathogenic |
— |
| RS113994012 |
EIF2B2
|
Health Risk |
Pathogenic/Likely pathogenic |
Vanishing white matter disease, See cases |
| RS113994014 |
EIF2B2
|
Health Risk |
Pathogenic |
Vanishing white matter disease, Leukoencephalopathy with vanishing white matter 2 |
| RS113994016 |
EIF2B2
|
Health Risk |
Pathogenic/Likely pathogenic |
Premature ovarian insufficiency, Vanishing white matter disease |
| RS113994017 |
EIF2B2
|
Health Risk |
Pathogenic |
Vanishing white matter disease, Vanishing white matter disease |
| RS113994018 |
EIF2B2
|
Health Risk |
Pathogenic/Likely pathogenic |
Vanishing white matter disease, Vanishing white matter disease |
| RS113994022 |
EIF2B3
|
Health Risk |
Pathogenic/Likely pathogenic |
Vanishing white matter disease, Leukoencephalopathy with vanishing white matter 3 |
| RS113994024 |
EIF2B3
|
Health Risk |
Pathogenic |
Leukoencephalopathy with vanishing white matter 3, Vanishing white matter disease |
| RS113994026 |
EIF2B3
|
Health Risk |
Pathogenic |
Leukoencephalopathy with vanishing white matter 3, Leukoencephalopathy with vanishing white matter 3 |
| RS113994027 |
EIF2B4
|
Health Risk |
Pathogenic |
Leukoencephalopathy with vanishing white matter 4, Leukoencephalopathy with vanishing white matter 4 |
| RS113994028 |
EIF2B4
|
Health Risk |
Conflicting classifications of pathogenicity |
Vanishing white matter disease, Inborn genetic diseases |
| RS113994030 |
EIF2B4
|
Health Risk |
Pathogenic/Likely pathogenic |
Vanishing white matter disease, Leukoencephalopathy with vanishing white matter 4 |
| RS113994032 |
EIF2B4
|
Health Risk |
Conflicting classifications of pathogenicity |
Leukoencephalopathy with vanishing white matter 4, Leukoencephalopathy with vanishing white matter 4 |